Compare KSS & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KSS | FMC |
|---|---|---|
| Founded | 1962 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1992 | N/A |
| Metric | KSS | FMC |
|---|---|---|
| Price | $17.69 | $13.59 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 14 | 13 |
| Target Price | $16.08 | ★ $21.67 |
| AVG Volume (30 Days) | 3.6M | ★ 4.9M |
| Earning Date | 03-10-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.82% | 2.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.73 | N/A |
| Revenue | ★ $15,751,000,000.00 | $3,467,400,000.00 |
| Revenue This Year | N/A | $15.16 |
| Revenue Next Year | N/A | $6.74 |
| P/E Ratio | $10.24 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.04 | $12.17 |
| 52 Week High | $25.22 | $44.78 |
| Indicator | KSS | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 37.21 |
| Support Level | $17.31 | $12.48 |
| Resistance Level | $18.82 | $16.97 |
| Average True Range (ATR) | 0.77 | 0.83 |
| MACD | 0.11 | -0.23 |
| Stochastic Oscillator | 70.85 | 28.70 |
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.